UA41863C2 - Спосіб одержання гетерологічного поліпептиду в еукаріотичних мікроорганізмах - Google Patents
Спосіб одержання гетерологічного поліпептиду в еукаріотичних мікроорганізмахInfo
- Publication number
- UA41863C2 UA41863C2 UA4203156A UA4203156A UA41863C2 UA 41863 C2 UA41863 C2 UA 41863C2 UA 4203156 A UA4203156 A UA 4203156A UA 4203156 A UA4203156 A UA 4203156A UA 41863 C2 UA41863 C2 UA 41863C2
- Authority
- UA
- Ukraine
- Prior art keywords
- heterologous polypeptide
- signal peptide
- eukaryotic microorganisms
- bari
- lys
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
- C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/62—Insulins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
- C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
- C12N15/815—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts for yeasts other than Saccharomyces
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/58—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from fungi
- C12N9/60—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from fungi from yeast
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/10—Fusion polypeptide containing a localisation/targetting motif containing a tag for extracellular membrane crossing, e.g. TAT or VP22
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/50—Fusion polypeptide containing protease site
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
- C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
- C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Mycology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Plant Pathology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US79130585A | 1985-10-25 | 1985-10-25 | |
PCT/US1986/002198 WO1987002670A1 (en) | 1985-10-25 | 1986-10-20 | Method of using bar1 for secreting foreign proteins |
Publications (1)
Publication Number | Publication Date |
---|---|
UA41863C2 true UA41863C2 (uk) | 2001-10-15 |
Family
ID=25153298
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UA4203156A UA41863C2 (uk) | 1985-10-25 | 1986-10-20 | Спосіб одержання гетерологічного поліпептиду в еукаріотичних мікроорганізмах |
Country Status (13)
Country | Link |
---|---|
EP (1) | EP0243465A1 (ja) |
JP (1) | JP2523562B2 (ja) |
CN (1) | CN1027179C (ja) |
AU (2) | AU6543286A (ja) |
CA (1) | CA1316133C (ja) |
CZ (1) | CZ284251B6 (ja) |
DK (1) | DK320287D0 (ja) |
FI (1) | FI872801A (ja) |
HU (1) | HU206897B (ja) |
IE (1) | IE63822B1 (ja) |
SK (1) | SK279041B6 (ja) |
UA (1) | UA41863C2 (ja) |
WO (1) | WO1987002670A1 (ja) |
Families Citing this family (54)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK58285D0 (da) * | 1984-05-30 | 1985-02-08 | Novo Industri As | Peptider samt fremstilling og anvendelse deraf |
CA1314830C (en) * | 1987-10-02 | 1993-03-23 | Susan K. Welch | Bar1 secretion signal |
US5206699A (en) * | 1988-05-06 | 1993-04-27 | Gersan Establishment | Sensing a narrow frequency band of radiation and gemstones |
ATE135045T1 (de) * | 1988-07-23 | 1996-03-15 | Delta Biotechnology Ltd | Sekretorische leader-sequenzen |
WO1991013971A1 (en) * | 1990-03-13 | 1991-09-19 | Hawaii Biotechnology Group, Inc. | Neurospora expression system |
DK82893D0 (da) * | 1993-07-08 | 1993-07-08 | Novo Nordisk As | Peptid |
AU715423B2 (en) | 1995-03-17 | 2000-02-03 | Novozymes A/S | Novel endoglucanases |
DE69717092T2 (de) | 1996-03-01 | 2003-07-24 | Novo Nordisk As | Gebrauch einer pharmazeutischen Zusammensetzung, enthaltend ein appetitzügelndes Peptid |
CA2395713C (en) | 2000-01-10 | 2012-04-10 | Torben Lauesgaard Nissen | G-csf conjugates |
CN100488562C (zh) | 2000-02-11 | 2009-05-20 | 拜耳医药保健有限公司 | 凝血因子VⅡ或VⅡa样分子 |
EP2080771A3 (en) | 2001-02-27 | 2010-01-06 | Maxygen Aps | New interferon beta-like molecules |
ES2432967T3 (es) | 2001-03-22 | 2013-12-05 | Novo Nordisk Health Care Ag | Derivados del Factor VII de coagulación |
US6534059B2 (en) | 2001-06-05 | 2003-03-18 | Advanced Biotherapy, Inc. | Compositions and methods for treating hyperimmune response in the eye |
ATE532858T1 (de) | 2001-09-27 | 2011-11-15 | Novo Nordisk Healthcare Ag | Menschliche gerinnungsfaktor-vii-polypeptide |
CN101870729A (zh) | 2003-09-09 | 2010-10-27 | 诺和诺德医疗保健公司 | 凝固因子ⅶ多肽 |
KR20080013878A (ko) | 2005-04-18 | 2008-02-13 | 노보 노르디스크 에이/에스 | Il-21 변이체 |
JP5366546B2 (ja) | 2005-08-16 | 2013-12-11 | ノボ・ノルデイスク・エー/エス | 成熟インスリンポリペプチドの作製方法 |
US20090055942A1 (en) | 2005-09-14 | 2009-02-26 | Novo Nordisk Healthcare A/G | Human Coagulation Factor VII Polypeptides |
EP1996186A4 (en) | 2006-03-06 | 2009-07-22 | Humagene Inc | PROCESS FOR THE PREPARATION OF RECOMBINANT HUMAN THROMBIN AND FIBRINOGEN |
JP5840345B2 (ja) | 2006-09-08 | 2016-01-06 | アンブルックス, インコーポレイテッドAmbrx, Inc. | 修飾ヒト血漿ポリペプチドまたは修飾ヒトFc足場タンパク質ならびにこれらの利用 |
US8518668B2 (en) | 2006-09-27 | 2013-08-27 | Novo Nordisk A/S | Method for making maturated insulin polypeptides in a fungal cell |
JP2010525821A (ja) | 2007-05-02 | 2010-07-29 | アンブルックス,インコーポレイテッド | 修飾IFNβポリペプチドおよびこれらの使用 |
DK2217265T3 (en) | 2007-11-20 | 2017-07-03 | Ambrx Inc | Modified insulin polypeptides and their use |
BRPI0916515B8 (pt) | 2008-07-23 | 2021-07-27 | Ambrx Inc | polipeptídeo de fator estimulante de colônias de granulócitos bovino (bg-csf), formulação farmacêutica e composição compreendendo o mesmo |
US8349325B2 (en) | 2008-12-23 | 2013-01-08 | Abbott Laboratories | Soluble FMS-like tyrosine kinase-1 (sFLT-1) antibody and related composition, kit, methods of using, and materials and method for making |
EP2406282A1 (en) | 2009-03-11 | 2012-01-18 | Novo Nordisk A/S | Interleukin-21 variants having antagonistic binding to the il-21 receptor |
CN107513103A (zh) | 2009-07-17 | 2017-12-26 | 丹麦国家医院 | 作为补体激活的抑制剂的masp同种型 |
CN102666570B (zh) | 2009-12-01 | 2015-12-02 | 诺沃—诺迪斯克有限公司 | 新的肽基α-羟基甘氨酸α-酰胺化裂合酶 |
CN102753573A (zh) | 2009-12-21 | 2012-10-24 | Ambrx公司 | 经过修饰的牛促生长素多肽和其用途 |
AU2010341518B2 (en) | 2009-12-21 | 2014-01-09 | Ambrx, Inc. | Modified porcine somatotropin polypeptides and their uses |
EP3815708A1 (en) | 2010-03-05 | 2021-05-05 | Omeros Corporation | Chimeric inhibitor molecules of complement activation |
US20110229921A1 (en) | 2010-03-18 | 2011-09-22 | Abbott Laboratories | METHODS OF ASSAYING URINARY NEUTROPHIL GELATINASE-ASSOCIATED LIPOCALIN (uNGAL) IN THE PROGNOSIS OF CADAVERIC KIDNEY TRANSPLANT FUNCTION IN A PATIENT, INCLUDING A PATIENT DIAGNOSED WITH DELAYED GRAFT FUNCTION (DGF), A METHOD OF ASSAYING uNGAL IN THE ASSESSMENT OF RISK OF DGF IN A PATIENT DIAGNOSED WITH EARLY GRAFT FUNCTION (EGF), AND RELATED KITS |
US9551714B2 (en) | 2010-06-25 | 2017-01-24 | Abbott Laboratories | Materials and methods for assay of anti-hepatitis C virus (HCV) antibodies |
EP4302783A3 (en) | 2010-08-17 | 2024-03-13 | Ambrx, Inc. | Modified relaxin polypeptides and their uses |
TWI480288B (zh) | 2010-09-23 | 2015-04-11 | Lilly Co Eli | 牛顆粒細胞群落刺激因子及其變體之調配物 |
US20120115244A1 (en) | 2010-11-09 | 2012-05-10 | Abbott Laboratories | Materials and methods for immunoassay of pterins |
JP5940554B2 (ja) | 2010-12-09 | 2016-06-29 | アンスティテュ・パストゥールInstitut Pasteur | 高収量の組換えタンパク質発現を得るためのmgmtに基づく方法 |
MX349562B (es) | 2011-12-09 | 2017-08-02 | Pasteur Institut | Ensayo de inmuno deteccion multiplex. |
US8993248B2 (en) | 2011-12-31 | 2015-03-31 | Abbott Laboratories | Truncated human vitamin D binding protein and mutation and fusion thereof and related materials and methods of use |
US11787844B2 (en) | 2012-02-09 | 2023-10-17 | Var2 Pharmaceuticals Aps | Targeting of chondroitin sulfate glycans |
EP2906693A1 (en) | 2012-10-15 | 2015-08-19 | Novo Nordisk Health Care AG | Coagulation factor vii polypeptides |
JP2014128262A (ja) * | 2012-11-27 | 2014-07-10 | Kirin Brewery Co Ltd | 接合能を持つ酵母細胞株のスクリーニング方法 |
US20210108213A1 (en) | 2018-05-01 | 2021-04-15 | Ambrx, Inc. | A method for optimizing antibody expression |
EP3821244A1 (en) | 2018-07-13 | 2021-05-19 | Varct Diagnostics ApS | Isolation of circulating cells of fetal origin using recombinant malaria protein var2csa |
AU2019337610A1 (en) | 2018-09-11 | 2021-05-06 | Ambrx, Inc. | Interleukin-2 polypeptide conjugates and their uses |
JP2022512746A (ja) | 2018-10-19 | 2022-02-07 | アンブルックス,インコーポレイテッド | インターロイキン-10ポリペプチド複合体、その二量体、およびそれらの使用 |
US20220226488A1 (en) | 2019-02-12 | 2022-07-21 | Ambrx, Inc. | Compositions containing, methods and uses of antibody-tlr agonist conjugates |
EP4117732A1 (en) | 2020-03-11 | 2023-01-18 | Ambrx, Inc. | Interleukin-2 polypeptide conjugates and methods of use thereof |
CA3175523A1 (en) | 2020-04-13 | 2021-10-21 | Antti Virtanen | Methods, complexes and kits for detecting or determining an amount of a .beta.-coronavirus antibody in a sample |
US20220043000A1 (en) | 2020-08-04 | 2022-02-10 | Abbott Laboratories | Methods and kits for detecting sars-cov-2 protein in a sample |
JP2023538071A (ja) | 2020-08-20 | 2023-09-06 | アンブルックス,インコーポレイテッド | 抗体-tlrアゴニストコンジュゲート、その方法及び使用 |
EP4271998A1 (en) | 2020-12-30 | 2023-11-08 | Abbott Laboratories | Methods for determining sars-cov-2 antigen and anti-sars-cov-2 antibody in a sample |
IL307282A (en) | 2021-04-03 | 2023-11-01 | Ambrx Inc | Antidote conjugates against HER2 and their applications |
CN115806889A (zh) * | 2022-09-28 | 2023-03-17 | 山东大学 | 一种提高基因表达水平的酿酒酵母工程菌及其构建方法与应用 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4546082A (en) * | 1982-06-17 | 1985-10-08 | Regents Of The Univ. Of California | E. coli/Saccharomyces cerevisiae plasmid cloning vector containing the alpha-factor gene for secretion and processing of hybrid proteins |
US4613572A (en) * | 1983-08-15 | 1986-09-23 | Kansas State University Research Foundation | Yeast BAR1 gene plasmid |
DE3537176C2 (de) * | 1984-10-18 | 1994-06-09 | Zymogenetics Inc | Gewebeplasminogenaktivator und Verfahren zu seiner Herstellung |
JPS61247384A (ja) * | 1984-10-18 | 1986-11-04 | チモ−ジエネテイツクス インコ−ポレ−テツド | 酵母中でプラスミノ−ゲン活性化因子を発現する方法 |
-
1986
- 1986-10-20 JP JP61505713A patent/JP2523562B2/ja not_active Expired - Fee Related
- 1986-10-20 WO PCT/US1986/002198 patent/WO1987002670A1/en active Application Filing
- 1986-10-20 HU HU865248A patent/HU206897B/hu not_active IP Right Cessation
- 1986-10-20 AU AU65432/86A patent/AU6543286A/en not_active Abandoned
- 1986-10-20 UA UA4203156A patent/UA41863C2/uk unknown
- 1986-10-20 EP EP86906638A patent/EP0243465A1/en not_active Withdrawn
- 1986-10-23 IE IE280486A patent/IE63822B1/en not_active IP Right Cessation
- 1986-10-23 CA CA000521206A patent/CA1316133C/en not_active Expired - Fee Related
- 1986-10-25 CN CN86107554A patent/CN1027179C/zh not_active Expired - Lifetime
- 1986-10-27 CZ CS867764A patent/CZ284251B6/cs not_active IP Right Cessation
- 1986-10-27 SK SK7764-86A patent/SK279041B6/sk unknown
-
1987
- 1987-06-23 DK DK320287A patent/DK320287D0/da not_active Application Discontinuation
- 1987-06-24 FI FI872801A patent/FI872801A/fi not_active Application Discontinuation
-
1991
- 1991-04-02 AU AU74003/91A patent/AU676132B2/en not_active Ceased
Also Published As
Publication number | Publication date |
---|---|
AU676132B2 (en) | 1997-03-06 |
DK320287A (da) | 1987-06-23 |
CZ284251B6 (cs) | 1998-10-14 |
WO1987002670A1 (en) | 1987-05-07 |
AU6543286A (en) | 1987-05-19 |
EP0243465A1 (en) | 1987-11-04 |
FI872801A0 (fi) | 1987-06-24 |
DK320287D0 (da) | 1987-06-23 |
FI872801A (fi) | 1987-06-24 |
SK776486A3 (en) | 1998-06-03 |
AU7400391A (en) | 1991-07-18 |
IE862804L (en) | 1987-04-25 |
CN1027179C (zh) | 1994-12-28 |
JPS63501614A (ja) | 1988-06-23 |
IE63822B1 (en) | 1995-06-14 |
CA1316133C (en) | 1993-04-13 |
JP2523562B2 (ja) | 1996-08-14 |
CZ776486A3 (en) | 1996-09-11 |
HUT43624A (en) | 1987-11-30 |
HU206897B (en) | 1993-01-28 |
CN86107554A (zh) | 1987-08-26 |
SK279041B6 (sk) | 1998-06-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
UA41863C2 (uk) | Спосіб одержання гетерологічного поліпептиду в еукаріотичних мікроорганізмах | |
Clare et al. | Production of mouse epidermal growth factor in yeast: high-level secretion using Pichia pastoris strains containing multiple gene copies | |
CA1340547C (en) | Novel secretory leader sequences for yeasts | |
US5162220A (en) | Kex2 endoprotease without a c-terminal hydrophobic region | |
IE842193L (en) | Plasmid with tandem promoter system | |
EP0362179A3 (en) | Recombinant saccharomyces | |
EP0123544A3 (en) | Process for expressing heterologous protein in yeast, expression vehicles and yeast organisms therefor | |
US5234830A (en) | DNA encoding a KEX2 endoprotease without a C-terminal hydrophobic region | |
CA1195626A (en) | Recombinant dna cloning vectors and the eukaryotic and prokaryotic transformants thereof | |
KR930703450A (ko) | 합성 선도 서열의 작제방법 | |
MY102902A (en) | Lymphokine production and purification. | |
IE883896L (en) | Improved expression and secretion of heterologous proteins in yeast employing truncated alpha-factor leader sequences | |
YU177386A (en) | Process for obtaining and excreting of heterologic protein by using culture of y bacteria | |
US4929553A (en) | Protease for specific processing of secreted proteins | |
EP0111814A3 (en) | The cloning and expression of nucleotide sequences encoding bovine growth hormone | |
Brazzell et al. | Stimuli that induce a yeast heat shock gene fused to β-galactosidase | |
US5521093A (en) | Yeast vector coding for heterologous gene fusions linked via KEX2 cleavage site and coding for truncated KEX2 genes | |
EP0220689A3 (en) | Method of using bar1 for secreting foreign proteins | |
AU6633286A (en) | A method to export gene products to the growth medium of gram negative bacteria | |
MY103364A (en) | Synthetic porcine growth hormone | |
US5672496A (en) | DNA sequences encoding porcine pancreatic carboxypeptidase B | |
NZ216834A (en) | Production of bovine growth hormone by use of recombinant dna | |
ZA864800B (en) | High level production of swine growth hormone | |
IE873300L (en) | Expression vectors | |
EP0266057A3 (en) | Plasmid containing an eucaryotic secretory signal sequence and process for secreting encoded proteins |